Vontobel Holding Ltd. Decreases Holdings in McKesson Co. (NYSE:MCK)

Vontobel Holding Ltd. lessened its stake in shares of McKesson Co. (NYSE:MCK) by 19.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 63,042 shares of the company’s stock after selling 15,365 shares during the period. Vontobel Holding Ltd.’s holdings in McKesson were worth $35,928,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Synergy Asset Management LLC purchased a new stake in McKesson during the fourth quarter worth about $32,000. MidAtlantic Capital Management Inc. bought a new stake in shares of McKesson in the third quarter valued at approximately $29,000. Crews Bank & Trust purchased a new stake in shares of McKesson during the 4th quarter valued at approximately $33,000. Wolff Wiese Magana LLC boosted its holdings in McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after buying an additional 52 shares during the period. Finally, RPg Family Wealth Advisory LLC purchased a new position in McKesson in the 3rd quarter valued at approximately $31,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Trading Down 1.4 %

MCK opened at $593.82 on Friday. The stock has a market capitalization of $75.38 billion, a P/E ratio of 27.19, a PEG ratio of 1.30 and a beta of 0.52. The stock has a 50-day moving average price of $587.46 and a 200-day moving average price of $563.18. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, equities research analysts predict that McKesson Co. will post 32.69 EPS for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be paid a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.48%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson’s dividend payout ratio is presently 13.00%.

Insider Buying and Selling at McKesson

In other news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the sale, the executive vice president now owns 864 shares of the company’s stock, valued at approximately $494,890.56. The trade was a 40.12 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold a total of 1,346 shares of company stock worth $795,275 over the last three months. Company insiders own 0.11% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Bank of America cut their price target on McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a report on Monday, January 6th. Evercore ISI increased their price objective on McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th. StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday. Wells Fargo & Company increased their price target on shares of McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a report on Friday, December 13th. Finally, Mizuho began coverage on shares of McKesson in a research note on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $645.79.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.